Last year Home Diagnostics was sold to Nipro Corporation and the case here involves alleged information being given out before the transactions took place and of course there were those who benefited financially. The press release was from June of 2010 and you can read the archive here. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Other Items of Interest, My Commentaries, healthcare, CEO, Medical Devices, FDA, Diabetes, Glucose, Blood samples, Insider Trading, Profits, Mergers and Acquisitions, SEC, Nirpo, Home Diagnostics
NovoLog users can avoid a price spike by switching to another insulin, Humalog per United Healthcare and this is all a shake up of a bidding/contract situation, so who ever comes in at the lower bid moves to the cheap spot at tier 1 and the other ends up at the top level at tier 3, but no tier 2 in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Dec 6 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Medical Devices, FDA, Diabetes, insulin, Heatlhcare, China, UnitedHealthcare, Mergers and Acquisitions, Ingenix, Formularies, tiers, i3, ChinaGate